Trastorno por uso de cocaína y depresiónCuando el diagnóstico clínico no es suficiente

  1. María Alías-Ferri
  2. Nuria García-Marchena
  3. Joan Ignasi Mestre-Pintó
  4. Pedro Araos
  5. Esperanza Vergara-Moragues
  6. Francina Fonseca
  7. Francisco González-Saiz
  8. Fernando Rodríguez de Fonseca
  9. Marta Torrens
Revue:
Adicciones: Revista de socidrogalcohol

ISSN: 0214-4840

Année de publication: 2021

Volumen: 33

Número: 3

Pages: 193-200

Type: Article

DOI: 10.20882/ADICCIONES.1498 DIALNET GOOGLE SCHOLAR lock_openAccès ouvert editor

D'autres publications dans: Adicciones: Revista de socidrogalcohol

Résumé

Background: Cocaine use is a growing global health problem and patients with cocaine use disorders (CUD) present several complications, including high rates of major depression. These subjects present two types of major depressive disorder (MDD): primary major depressive disorder (P-MDD) and cocaine-induced major depressive disorder (CI-MDD). To improve treatment, it is necessary to distinguish between both types. The aim of this study was to assess the differences in depressive symptomatology criteria (P-MDD vs CI-MDD) in CUD patients. Methods: Secondary data analysis was carried out with a cross-sectional sample of 160 patients presenting CUD and MDD. Clinical assessment was performed using the Psychiatric Research Interview for Substance and Mental Disorders (PRISM). A differential diagnosis was obtained between P-MDD and CI-MDD. Results: Men represented 80% of the sample, the mean age was 38.61 years, and 64.5% had elementary studies. CI-MDD diagnosis (61.3%) was more frequent than P-MDD (38.7%). There was a younger age of CUD onset in CI-MDD patients. In addition, 79.4% of the patients had another substance use disorder diagnosis. The criterion “Changes in weight or appetite” was more prevalent (57.1%) in P-MDD group. Conclusions: We found differences in the criterion “Changes in weight or appetite”. Further research is needed in this field to establish a differential diagnosis and thus provide better treatment for CUD patients. Keywords: Dual diagnosis; cocaine use disorder; cocaine-related disorders; depressive disorder; induced depression.

€ Voir financement

Information sur le financement

This work was supported by: Instituto de Salud Carlos III–FEDER-Red de Trastornos Adictivos UE-FEDER 2016 (RD16/0017/0010 and RD16/0017/0001); FONDO DE INVESTIGACIÓN SANITARIA. ISCIII (PI14/00178); Research project funded by Ministerio de Sanidad, Servi-cios Sociales e Igualdad and Plan Nacional sobre Drogas (PNSD-2018I044); Research project funded by Ministerio de Sanidad, Servicios Sociales e Igualdad and Plan Nacio-nal sobre Drogas (043/2017); Research project funded by Consejería de Economía, Innovación y Ciencia, Junta de Andalucía and ERDF-EU (CTS-433); Research projects funded by Consejería de Salud y Bienestar Social, Junta de Andalucía-Fundación Progreso y Salud (EF-0202-2017 and PI-0140-2018) and Research Project funded by Uni-versidad de Málaga-Incorporación a Doctores, Plan Propio (CI-17-415); Acció instrumental d’Intensificació de Professionals de la Salut - Facultatius especialistes (PERIS: SLT006/17/00014); Plan Nacional de Drogas de España (PND no. 2007i078); AGAUR-Suport Grups de Recerca (2017 SGR530).

Financeurs

Références bibliographiques

  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed. Washington, DC: APA.
  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: APA.
  • Araos, P., Vergara-Moragues, E., Pedraz, M., Pavón, F. J., Campos Cloute, R., Calado, M.,… Rodríguez de Fonseca, F. (2014). Psychopathological comorbidity in cocaine users in outpatient treatment.Adicciones, 26, 15–26. doi:10.20882/adicciones.124
  • Araos, P., Vergara-Moragues, E., González-Saiz, F., Pedraz, M., García-Marchena, N., Romero-Sanchiz, P.,… Rodriguez De Fonseca, F. (2017). Differences in the rates of drug polyconsumption and psychiatric comorbidity among patients with cocaine use disorders according to the mental health service. Journal of Psychoactive Drugs, 49, 306–315. doi:10.1080/02791072.2017.1342151.
  • Bobes, B. M., Flórez, G., Seijo, P. y Bobes, G. J. (2019). Does ICD-11 improve the epidemiological and nosological purposes of mental, behavioral and developmental disorders? Adicciones, 31, 183. doi:10.20882/adicciones.1368.
  • Cohn, A. M., Epstein, E. E., McCrady, B. S., Jensen, N., Hunter-Reel, D., Green, K. E. y Drapkin, M. L. (2011). Pretreatment clinical and risk correlates of substance use disorder patients with primary depression. Journal of Studies on Alcohol and Drugs, 72, 151–157. doi: 10.15288/ jsad.2011.72.151.
  • Conner, K. R., Gamble, S. A., Bagge, C. L., He, H., Swogger,M. T., Watts, A. y Houston, R. J. (2014). Substance-induced depression and independent depression in proximal risk for suicidal behavior. Journal of Studies on Alcohol and Drugs, 75, 567–572. doi:10.15288/jsad.2014.75.567.
  • Dakwar, E., Nunes, E. V., Bisaga, A., Carpenter, K. C., Mariani, J. P., Sullivan, M. A.,… Levin, F. R. (2011). A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers. American Journal on Addictions, 20, 441–446. doi:10.1111/j.1521-0391.2011.00148.x.
  • Davis, L., Uezato, A., Newell, J. M. y Frazier, E. (2008). Major depression and comorbid substance use disorders. Current Opinion in Psychiatry, 21, 14–18. doi:10.1097/ YCO.0b013e3282f32408.
  • Foulds, J. A., Sellman, J. D., Adamson, S. J., Boden, J. M., Mulder, R. T. y Joyce, P. R. (2015). Depression outcome in alcohol dependent patients: An evaluation of the role of independent and substance-induced depression and other predictors. Journal of Affective Disorders, 174, 503–510. doi:10.1016/j.jad.2014.11.052.
  • García-Fernández, G., Secades-Villa, R., García-Rodríguez, O., Peña-Suárez, E. y Sánchez-Hervás, E. (2013). Contingency management improves outcomes in cocaine-dependent outpatients with depressive symptoms. Experimental and Clinical Psychopharmacology, 21, 482-489. doi:10.1016/j.jsat.2012.08.018.
  • Grant, B. F. y Dawson, D. A. (1998). Age of onset of drug use and its association with DSM-IV drug abuse and dependence: Results from the national longitudinal alcohol epidemiologic survey. Journal of Substance Abuse, 10, 163–173. doi:10.1016/s0899-3289(97)90009-2.
  • Hasin, D. S., Samet, W. E., Nunes, J., Meydan, K., Matseoane, B. A. R. y Waxman, B. A. (2006). Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. American Journal of Psychiatry, 163, 689-696.
  • Herrero, M. J., Domingo-Salvany, A., Torrens, M., Brugal, M. T. y ITINERE Investigators. (2008). Psychiatric comorbidity in young cocaine users: Induced versus independent disorders. Addiction, 103, 284–293. doi:10.1111/j.1360-0443.2007.02076.x.
  • Herrero, M. J., Domingo-Salvany, A., Brugal, M. T., Torrens, M. y ITINERE Investigators. (2011). Incidence of psychopathology in a cohort of young heroin and/ or cocaine users. Journal of Substance Abuse Treatment, 41, 55–63. doi:10.1176/ajp.2006.163.4.689.
  • John, W. S. y Wu, L. T. (2017). Trends and correlates of cocaine use and cocaine use disorder in the United States from 2011 to 2015. Drug and Alcohol Dependence, 180, 376–384. doi:10.1016/j.drugalcdep.2017.08.031.
  • Jordan, C. J. y Andersen, S. L. (2017). Sensitive periods of substance abuse: Early risk for the transition to dependence. Developmental Cognitive Neuroscience, 25, 29–44. doi:10.1016/j.dcn.2016.10.004.
  • Keller, B., Mestre-Pinto, J.-I., Álvaro-Bartolomé, M., Martinez-Sanvisens, D., Farre, M., García-Fuster, M. J., NEURODEP Group. (2017). A biomarker to differentiate between primary and cocaine-induced major depression in cocaine use disorder: The role of platelet IRAS/Nischarin (I1-Imidazoline Receptor). Frontiers in Psychiatry, 8, 258. doi:10.3389/fpsyt.2017.00258.
  • Lai, H. M. X., Cleary, M., Sitharthan, T. y Hunt, G. E. (2015). Prevalence of comorbid substance use, anxietyand mood disorders in epidemiological surveys, 1990– 2014: A systematic review and meta-analysis. Drug and Alcohol Dependence, 154, 1–13. doi:10.1016/j.drugalcdep.2015.05.031.
  • Langås, A. M., Malt, U. F. y Opjordsmoen, S. (2013). Independent versus substance-induced major depressive disorders in first-admission patients with substance use disorders: An exploratory study. Journal of Affective Disorders, 144, 279–283. doi:10.4088/jcp.v67n1010.
  • Leventhal, A. M., Mooney, M. E., DeLaune, K. A. y Schmitz,J. M. (2006). Using addiction severity profiles to differentiate cocaine- dependent patients with and without comorbid major depression. American Journal on Addictions, 15, 362–369. doi:10.1080/10550490600860148.
  • Magidson, J. F., Wang, S., Lejuez, C. W., Iza, M. y Blanco,C. (2013). Prospective study of substance-induced and independent major depressive disorder among individuals with substance use disorders in a nationally representative sample. Depression and Anxiety, 30, 538–545. doi:10.1002/da.22122.
  • Nunes, E. V, Liu, X., Samet, S., Matseoane, K. y Hasin, D. (2006). Independent versus substance-induced major depressive disorder in substance-dependent patients: Observational study of course during follow-up. Journal of Clinical Psychiatry, 67, 1561–1567. doi:10.4088/jcp. v67n1010.
  • Raimo, E. B. y Schuckit, M. A. (1998). Alcohol dependence and mood disorders. Addictive Behaviors, 23, 933-946. doi:10.1016/s0306-4603(98)00068-9.
  • Saltiel, P. F. y Silvershein, D. I. (2015). Major depressive disorder: Mechanism-based prescribing for personalized medicine. Neuropsychiatric Disease and Treatment, 11, 875- 888. doi:10.2147/NDT.S73261.
  • Samet, S., Fenton, M. C., Nunes, E., Greenstein, E., Aharonovich, E. y Hasin, D. (2013). Effects of independent and substance-induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence. Addiction, 108, 115–123. doi:10.1111/j.1360- 0443.2012.04010.x.
  • Schuckit, M. A., Tipp, J. E., Bergman, M., Reich, W., Hesselbrock, V. M. y Smith, T. L. (1997). Comparison of induced and independent major depressive disorders in 2,945 alcoholics. American Journal of Psychiatry, 154, 948–957. doi:10.1176/ajp.154.7.948.
  • Tirado Muñoz, J., Farré, A., Mestre-Pintó, J., Szerman, N. y Torrens, M. (2018). Dual diagnosis in depression: Treatment recommendations. Adicciones, 30, 66-76. doi:10.20882/adicciones.868.
  • Torrens, M., Serrano, D., Astals, M., Pérez-Domínguez, G. y Martín-Santos, R. (2004). Diagnosing comorbid psychiatric disorders in substance abusers: Validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. American Journal of Psychiatry, 161, 1231–1237. doi:10.1176/appi.ajp.161.7.1231.
  • Torrens, M. (2008). Patología dual: Situación actual y retos de futuro. Adicciones, 20, 315–319. doi:10.20882/adicciones.255.
  • United Nations Office on Drugs and Crime (UNODC). (2016a). Annual prevalence of the use of drugs by region and globally | Statistics and Data.
  • United Nations Office on Drugs and Crime (UNODC). (2016b). Drug treatment in Europe | Statistics and Data.
  • Yang, B.-Z., Han, S., Kranzler, H. R., Farrer, L. A. y Gelernter, J. (2011). A genomewide linkage scan of cocaine dependence and major depressive episode in two populations. Neuropsychopharmacology, 36, 2422–2430. doi:10.1038/npp.2011.122.
La source de données: Dialnet